Philips announced today that it received a second round of funding from the Bill & Melinda Gates Foundation for its ultrasound technology. The funding goes toward accelerating the global adoption of AI algorithms on the Philips Lumify handheld ultrasound system. Philips’ system utilizes AI to simplify key measurements to identify abnormalities during pregnancy. This can […]
Women's Health
Cooper Companies spends $300M on some Cook Medical product lines
Cook Medical today agreed to sell some reproductive health and otolaryngology product lines to Cooper Cos., the companies announced. The purchase price was $300 million. The products in the sale represent about 2.5% of Cook Medical’s sales. Manufacturing will get transferred to Cooper Cos. over a two-year period. The news comes about three months after […]
Clarix Imaging raises $10M for surgical oncology imaging tech
Clarix Imaging announced that it secured $10 million in funding to support its volumetric specimen imaging system. The state-of-the-art, point-of-care 3D imaging platform enables the real-time assessment of surgical specimens in the operating room. Its uses include oncology, with the potential to benefit the 300,000 patients diagnosed with breast cancer in the U.S. each year. […]
Hologic launches global outreach partnership for Breast Cancer Awareness Month
Hologic today announced a series of activities for October — Breast Cancer Awareness Month. The slate of activities promotes the importance of breast cancer screenings. It includes a global partnership with Know Your Lemons, a non-profit committed to improving early breast cancer detection. Know Your Lemons provides creative and empowering education on the topic. Marlborough, […]
Hologic, Bayer partner on improved mammography imaging
Hologic and Bayer today announced an international partnership focused on improving breast cancer detection. The companies teamed up to deliver contrast-enhanced mammography (CEM) solutions across Europe, Canada and Asia Pacific. CEM, a highly sensitive, relatively low-cost breast imaging modality, combines digital mammography with contrast agent administration. It supports breast cancer diagnosis and guides treatment decisions. […]
FDA grants de novo nod to BlueWind Medical’s neuromod for urinary incontinence
BlueWind Medical announced today that the FDA granted a de novo marketing request for its Revi neuromodulation system. Park City, Utah-based BlueWind designed Revi as a tibial neuromodulation system for treating the symptoms of incontinence. It treats urgency incontinence alone or in combination with urinary urgency. De novo approval for men and women with urge […]
iCad to integrate Google AI into mammography workflow
iCad (Nasdaq:ICAD) announced today that it amended its development and commercialization agreement with Google Health. The amendment enables iCad to integrate Google’s AI technology with its ProFound Breast Health Suite for 2D mammography. It intends to integrate the AI capabilities upon regulatory approval as an independent reader for breast cancer screening. ProFound Detection, a high-performance […]
Accuray gets FDA nod for breast cancer treatment on Radixact system
Accuray (Nasdaq:ARAY) announced that the FDA granted 510(k) clearance to its VitalHold breast package on the Radixact system. The company also says it expects the treatment option to become available in Europe. VitalHold facilitates deep inspiration breath hold (DIBH) treatments. It uses the Radixact System’s fixed beam angle delivery mode (TomoDirect) and fully integrated, automated […]
Cooper Companies abandons $875M Cook Medical Reproductive Health business acquisition
The FTC issued a statement announcing that it learned that the Cooper Companies terminated its planned acquisition of a Cook Medical business. In February 2022, Cook Medical signed a letter of intent to sell its Reproductive Health business to CooperCompanies. The deal totaled $875 million. Cooper agreed to pay $675 million at closing and the […]
Hologic stock dips on Q3 losses, questions over future margins
Hologic shares fell this morning despite third-quarter results that topped the consensus forecast. Shares of HOLX dipped 4% at $76.29 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell 0.6%. The Marlborough, Massachusetts-based women’s health and diagnostics company posted losses of $40.5 […]
Integra Lifesciences completes enrollment in DuraSorb monofilament mesh IDE study
Integra LifeSciences announced that it completed enrollment ints U.S. DuraSorb trial. The FDA investigational device exemption (IDE) clinical study evaluates DuraSorb in two-stage breast reconstruction. The bioabsorbable matrix-based monofilament mesh currently has FDA clearance to reinforce soft tissue where weakness exists. Princeton, New Jersey-based Integra said its study marks the first and only active, multi-center […]